# HF Prevalence and Evolution of HF in DM II Patients at High Risk

> **NCT04482283** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 245 (actual)

## Conditions studied

- RELATED REGISTRY SEARCH

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04482283
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-20
- **Primary completion:** 2024-11-21
- **Final completion:** 2024-11-21
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04482283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04482283, "HF Prevalence and Evolution of HF in DM II Patients at High Risk". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04482283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*